pHTN HaloTag CMV-neo

Mammalian expression vector with a traditional MCS and ampicillin and G418 resistance markers, encoding a cleavable N-terminal HaloTag®.

Sequence Author: Promega

|Download SnapGene Viewer
Explore Over 2.7k Plasmids: Mammalian Expression Vectors | More Plasmid Sets
No matches
BglII (6138) MluI (6019) BspEI (5806) PciI (5042) AgeI (4974) AhdI (4872) XmnI (4272) BamHI (3840) BstXI (3767) RsrII (3562) NaeI (3548) NgoMIV (3546) PluTI (3049) BsrGI (96) SpeI (152) NdeI (387) T7 promoter NheI (1052) BmtI (1056) PflMI (1108) AleI (1166) BstEII (1184) BmgBI (1318) PasI (1348) BclI * (1548) PshAI (1613) SgrAI (1700) TspMI - XmaI (1870) SmaI (1872) SalI (1936) AccI (1937) PaeR7I - XhoI (1943) TEV site AsiSI - PvuI (2001) EcoRI (2009) Eco53kI (2018) SacI (2020) SacII (2027) EcoRV (2031) XbaI (2033) PspOMI (2042) ApaI (2046) SbfI (2057) NotI (2066) BlpI (2097) PsiI (2245) HpaI (2265) MfeI (2274) Acc65I (2502) KpnI (2506) CsiI - SexAI * (2619) SfiI (2805) AvrII (2852) KasI (3045) NarI (3046) SfoI (3047) pHTN HaloTag® CMV-neo 6143 bp
BglII  (6138)
1 site
A G A T C T T C T A G A
MluI  (6019)
1 site
A C G C G T T G C G C A
BspEI  (5806)
1 site
T C C G G A A G G C C T
PciI  (5042)
1 site
A C A T G T T G T A C A

PciI is inhibited by nonionic detergents.
AgeI  (4974)
1 site
A C C G G T T G G C C A
AhdI  (4872)
1 site
G A C N N N N N G T C C T G N N N N N C A G

The 1-base overhangs produced by AhdI may be hard to ligate.
Sticky ends from different AhdI sites may not be compatible.
XmnI  (4272)
1 site
G A A N N N N T T C C T T N N N N A A G
BamHI  (3840)
1 site
G G A T C C C C T A G G

After cleavage, BamHI-HF® (but not the original BamHI) can remain bound to DNA and alter its electrophoretic mobility.
BstXI  (3767)
1 site
C C A N N N N N N T G G G G T N N N N N N A C C

Sticky ends from different BstXI sites may not be compatible.
RsrII  (3562)
1 site
C G G W C C G G C C W G G C

Efficient cleavage requires at least two copies of the RsrII recognition sequence.
Sticky ends from different RsrII sites may not be compatible.
For full activity, add fresh DTT.
NaeI  (3548)
1 site
G C C G G C C G G C C G

Efficient cleavage requires at least two copies of the NaeI recognition sequence.
NgoMIV  (3546)
1 site
G C C G G C C G G C C G

Efficient cleavage requires at least two copies of the NgoMIV recognition sequence.
PluTI  (3049)
1 site
G G C G C C C C G C G G

Efficient cleavage requires at least two copies of the PluTI recognition sequence.
BsrGI  (96)
1 site
T G T A C A A C A T G T

BsrGI is typically used at 37°C, but is even more active at 60°C.
SpeI  (152)
1 site
A C T A G T T G A T C A
NdeI  (387)
1 site
C A T A T G G T A T A C

Prolonged incubation with NdeI may lead to removal of additional nucleotides.
NheI  (1052)
1 site
G C T A G C C G A T C G
BmtI  (1056)
1 site
G C T A G C C G A T C G
PflMI  (1108)
1 site
C C A N N N N N T G G G G T N N N N N A C C

Sticky ends from different PflMI sites may not be compatible.
AleI  (1166)
1 site
C A C N N N N G T G G T G N N N N C A C
BstEII  (1184)
1 site
G G T N A C C C C A N T G G

Sticky ends from different BstEII sites may not be compatible.
BstEII is typically used at 60°C, but is 50% active at 37°C.
BmgBI  (1318)
1 site
C A C G T C G T G C A G

This recognition sequence is asymmetric, so ligating blunt ends generated by BmgBI will not always regenerate a BmgBI site.
PasI  (1348)
1 site
C C C W G G G G G G W C C C

Sticky ends from different PasI sites may not be compatible.
BclI  (1548)
1 site
T